Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan: PDS Biotechnology (PDSB)
PDS Biotechnology management is effectively minimizing scientific risks by developing partnerships with industry behemoths. The quarterly EPS growth history on the general GURU.Markets platform chart confirms this trajectory, where the value of 14.60 reflects the metric's balance. Versamune technology enables the creation of universal tumor medications while optimizing costs, and the company's research capacities are fully prepared for the industrial scaling of these drugs.
Rincian metrik komprehensif lan analitis PDS Biotechnology (PDSB)
- rega saham lan prakiraan rega para ahli:
- indikator kapitalisasi bursa perusahaan:
- data kapitalisasi buku:
- rincian utang lan likuiditas:
Utang marang Ekuitas PDS Biotechnology|PDSB - Rasio utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas pdsbiotech.com|PDSB - Utang kumulatif perusahaan|Utang marang nilai buku PDS Biotechnology Corp|PDSB - Tanggungan jangka dawa|Kewajiban jangka cendhak perusahaan PDS Biotechnology|Rasio cepet pdsbiotech.com
- rincian bathi lan kelipatan pasar:
PDSB - Bathi pungkasan|Proyeksi bathi mangsa ngarep PDS Biotechnology|PDSB - Kapitalisasi marang bathi|Rega marang bathi mangsa ngarep pdsbiotech.com|PDSB - Koefisien bali modal nimbang wutah|Pangali EV/EBITDA PDS Biotechnology Corp|PDSB - Bathi operasional EBITDA|Bathi saben saham sajrone rolas wulan pungkasan PDS Biotechnology|PDSB - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan pdsbiotech.com|PDSB - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep PDS Biotechnology
Analisis komprehensif perusahaan:PDS Biotech, PDSB
PDS Biotechnology operates within an isolated product cycle where stable demand for biotechnology offsets macroeconomic risks. The earnings per share (EPS) dynamics quantify this resilience, measuring net income growth rates per quarter without time lags; analyzing the quarterly EPS growth trend allows investors to assess the fundamental viability of the business and promptly identify risks of the asset being overbought.
Pesaing PDS Biotechnology
IBRX: Wutah bathi EPS kuartalan|IMCR - Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Janux Pharma|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan Arcus Corp (RCUS)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Zymeworks Inc. (ZYME)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan tangotx.com TNGX|Iovance Biotherapeutics, Inc. - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan Immatics NV IMTX|XNCR - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|CMPX (Compass Therapeutics Corp) - Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan|Replimune Group, Inc. (REPL) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan lyell.com (LYEL)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan IPHA|PYXS - Wutah bathi resik saben saham sajroning taun lumaku|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan CGEN (Compugen Ltd.)|Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan IOBT|Wutah bathi EPS kuartalan STRO (Sutro Biopharma, Inc.)|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan INKT|Werewolf - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Immix Biopharma, Inc.|ALX Oncology (ALXO) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Cue Biopharma Inc. - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|SONN (Sonnet BioTherapeutics Holdings, Inc.) - Wutah bathi EPS kuartalan|Wutah bathi EPS kuartalan MAIABiotech.com|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Liminatus Pharma LLC (LIMN)|LVTX: Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|NextCure Corp - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Leap Therapeutics Inc (LPTX) - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|INTS - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan SNSE|TOVX: Wutah bathi EPS kuartalan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan GRTS|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Kineta Bio|NexImmune Corporation (NEXI) - Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan TSBX (Turnstone Biologics)|VCNX (vaccinex.com) - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan HARP (Harpoon Therapeutics, Inc.)
